Comparative effectiveness of adalimumab versus infliximab in children with Crohn's disease: real-world data from the prospective PIBD-SETQuality inception cohort study

Results

Naziv:	Comparative effectiveness of adalimumab versus infliximab in children with Crohn's disease: real-world data from the prospective PIBD-SETQuality inception cohort study
Autori :	Vuijk, Stephanie A; Klomberg, Renz CW; Katgert, Eva; Wessels, Margreet MS; Miele, Erasmo; Cameron, Fiona L; Milovanovich, Ivan D; Muhammed, Rafeeq; Devadason, David; Hart, James; Rizopoulos, Dimitris; Croft, Nicholas M; De, Ridder Lissy;
Godina:	2026
Publikacija:	CROHNS & COLITIS 360
ISSN:	2631-827X CROHNS & COLITIS 360 Pretraži identifikator
Tip rezultata:	Naučni članak
Kolacija:	vol. 8 br. 3
DOI:	10.1093/crocol/otag069
WoS-ID:	001838629600001
Scopus-ID:	2-s2.0-105046332789
URI:	https://enauka.gov.rs/handle/123456789/1049911
Projekat:	The PIBD-SETQuality European Union's Horizon 2020 Research and Innovation [668023]
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	22M22 - Međunarodni časopis kategorije M22

Altmetric

Dimensions

Unpaywall